|  | Diabetes status at cancer diagnosis |  | ||||
---|---|---|---|---|---|---|---|
 | Overall (N = 2,418) | Previously diagnosed (n = 1,784) | Previously undiagnosed (n = 634) | P-value | |||
 | N | % (SD) | n | % (SD) | n | % (SD) |  |
Age at cancer diagnosis (years) | |||||||
66-70 | 326 | 13.5% | 234 | 13.1% | 92 | 14.5% | 0.77 |
71-75 | 529 | 21.9% | 397 | 22.3% | 132 | 20.8% | |
76-80 | 594 | 24.6% | 437 | 24.5% | 157 | 24.8% | |
>80 | 969 | 40.1% | 716 | 40.1% | 253 | 39.9% | |
Mean & (SD) age | 77.8 | 6.9 | 77.8 | 7.0 | 77.7 | 6.9 | |
Race/ethnicity | |||||||
White | 2,156 | 89.2% | 1,584 | 88.8% | 572 | 90.2% | 0.47 |
Black | 132 | 5.5% | 103 | 5.8% | 29 | 4.6% | |
Hispanic | 89 | 3.7% | 64 | 3.6% | 25 | 3.9% | |
Other | 41 | 1.7% | 33 | 1.8% | 8 | 1.3% | |
Year of diagnosis | |||||||
2001 | 464 | 19.2% | 322 | 18.0% | 142 | 22.4% | 0.05 |
2002 | 482 | 19.9% | 347 | 19.5% | 135 | 21.3% | |
2003 | 466 | 19.3% | 347 | 19.5% | 119 | 18.8% | |
2004 | 468 | 19.4% | 363 | 20.3% | 105 | 16.6% | |
2005 | 538 | 22.2% | 405 | 22.7% | 133 | 21.0% | |
Stage at diagnosis | |||||||
In situ | 274 | 11.3% | 217 | 12.2% | 57 | 9.0% | <0.0001 |
I | 920 | 38.0% | 705 | 39.5% | 215 | 33.9% | |
II | 786 | 32.5% | 579 | 32.5% | 207 | 32.6% | |
III | 239 | 9.9% | 175 | 9.8% | 64 | 10.1% | |
IV | 199 | 8.2% | 108 | 6.1% | 91 | 14.4% | |
Estrogen (ER) and progesterone (PR) receptor status | |||||||
ER and PR positive | 1,193 | 49.3% | 881 | 49.4% | 312 | 49.2% | Â |
ER or PR positive | 327 | 13.5% | 238 | 13.3% | 89 | 14.0% | 0.89 |
ER and PR negative | 324 | 13.4% | 244 | 13.7% | 80 | 12.6% | |
Unknown/missing | 574 | 23.7% | 421 | 23.6% | 153 | 24.1% | |
Histologic grade | |||||||
1 | 447 | 18.5% | 336 | 18.8% | 111 | 17.5% | 0.61 |
2 | 872 | 36.1% | 652 | 36.5% | 220 | 34.7% | |
3 | 696 | 28.8% | 502 | 28.1% | 194 | 30.6% | |
4 | 71 | 2.9% | 49 | 2.7% | 22 | 3.5% | |
Unknown/missing | 332 | 13.7% | 245 | 13.7% | 87 | 13.7% | |
NCI Comorbidity Index | |||||||
0 | 1,051 | 43.5% | 627 | 35.1% | 410 | 64.7% | <0.0001 |
1 | 699 | 28.9% | 560 | 31.4% | 145 | 22.9% | |
≥ 2 | 668 | 27.6% | 597 | 33.5% | 79 | 12.5% | |
Indicators of poor performance | |||||||
0 | 1,169 | 48.3% | 692 | 38.8% | 477 | 75.2% | <0.0001 |
≥ 1 | 1,249 | 51.7% | 1,092 | 61.2% | 157 | 24.8% | |
Types of physician visits | |||||||
Primary care and medical specialist | 1,621 | 67.0% | 1,277 | 71.6% | 344 | 54.3% | <0.0001 |
Primary care, no medical specialist | 381 | 15.8% | 254 | 14.2% | 127 | 20.0% | |
Medical specialist, no primary care | 226 | 9.3% | 154 | 8.6% | 72 | 11.4% | |
Other specialist only | 57 | 2.4% | 34 | 1.9% | 23 | 3.6% | |
None | 133 | 5.5% | 65 | 3.6% | 68 | 10.7% | |
Preventive services | |||||||
0 | 236 | 9.8% | 123 | 6.9% | 113 | 17.8% | <0.0001 |
1 | 403 | 16.7% | 294 | 16.5% | 109 | 17.2% | |
≥ 2 | 1,779 | 73.6% | 1,367 | 76.6% | 412 | 65.0% | |
Percent in census tract with some college | |||||||
<25% | 883 | 36.5% | 656 | 36.8% | 227 | 35.8% | 0.66 |
≥25% | 1,535 | 63.5% | 1,128 | 63.2% | 407 | 64.2% | |
Percent in census tract living in poverty | |||||||
<5% | 686 | 28.4% | 509 | 28.5% | 177 | 27.9% | 0.29 |
5-7% | 343 | 14.2% | 255 | 14.3% | 88 | 13.9% | |
8-12% | 542 | 22.4% | 383 | 21.5% | 159 | 25.1% | |
>12% | 847 | 35.0% | 637 | 35.7% | 210 | 33.1% | |
Type of geographic area | |||||||
Large metropolitan | 1,298 | 53.7% | 952 | 53.4% | 346 | 54.6% | 0.74 |
Metropolitan | 696 | 28.8% | 510 | 28.6% | 186 | 29.3% | |
Urban | 165 | 6.8% | 125 | 7.0% | 40 | 6.3% | |
Less urban/rural | 259 | 10.7% | 197 | 11.0% | 62 | 9.8% |